Evaluation of miglitol and voglibose effect on postprandial plasma glucose after test meal A loading

Journal of the Japan Diabetes Society

Volumn 51, Issue 5, 2008, Pages 411-418

  Uchida, Daigaku ^a,b   Nakamura, Susumu ^b   Yamane, Takamichi ^b   Onishi, Shunichiro ^b   Suzuki, Sawako ^b,c   Tatsuno, Ichiro ^c  

^a Hotaruno Central Naika   (Japan)

^b Department of Endocrinology and Metabolism   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 47049126279     PISSN: 0021437X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. The DECODE study group. European Diabetes Epidemiology Group (1999) Glucose tolerance and mortality : comparison of WHO and American Diabetes Association diagnostic criteria. Diabetes Epidemiology : Collaborative analysis Of Diagnostic criteria in Europe. Lancet 354 : 617-621
2. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T. Sekikawa A (1999) Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 22:920-924
3. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M : STOP-NIDDM Trail Research Group (2002) Acarbose for prevention of type 2 diabetes mellitus : the STOP-NIDDM randomised trial. Lancet 359:2072-2077
4. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M : STOP-NIDDM Trial Research Group (2003) Acarbose treatment and the risk of cardiovas-cular disease and hypertension in patients with impaired glucose tolerance : the STOP-NIDDM trial. JAMA 290:486-494
5. Hanefeld M, Cagatay M, Petrowitsch T, Neuser D, Petzinna D, Rupp M (2004) Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients : meta-analysis of seven long-term studies. Eur Heart J 25:10-16
6. Scott LJ, Spencer CM (2000) Miglitol : a review of its therapeutic potential in type 2 diabetes mellitus. Drugs 59:521-549
7. Karpe F (1999) Postprandial lipoprotein metabolism and atherosclerosis. J Intern Med 246:341-355
8. Parks EJ (2001) Recent findings in the study of postprandial lipemia. Curr Atheroscler Rep 3:462-470
9. Japanese source
10. Life Style Medicine 1: 19-25
11. Japanese source
12. Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, Ziegelasch HJ, Lindner J (1996) Risk factors for myocardial infarction and death in newly detected NIDDM : the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39:1577-1583
13. Hirano T, Oi K, Sakai S, Kashiwazaki K, Adachi M, Yoshino G. (1998) High prevalence of small dense LDL in diabetic nephropathy is not directly associated with kidney damage : a possible role of postprandial lipemia. Atherosclerosis 141:77-85
14. Simons LA, Dwyer T, Simons J, Bernstein L, Mock P, Poonia NS, Balasubramaniam S, Baron D, Branson J, Morgan J (1987) Chylomicrons and chylomicron remnants in coronary artery disease : a case-control study. Atherosclerosis 65:181-189
15. Brown AM, Wiggins D, Gibbons GF (1999) Glucose phosphorylation is essential for the turnover of neutral lipid and the second stage assembly of triacylglycerolrich ApoB-containing lipoproteins in primary hepatocyte cultures. Arterioscler Thromb Vase Biol 19:321 329
16. (Folia Pharmacol. Jpn.) 127: 223-232